Enhancing myocardial infarction treatment through bionic hydrogel-mediated spatial combination therapy via mtDNA-STING crosstalk modulation
Journal of Controlled Release · 2024-07 · 371 · 570-587
DOI: 10.1016/j.jconrel.2024.06.015 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Controlled Release, 2024-07. Verfasst von Zhi Zheng und 7 weiteren Autor:innen. Beteiligte Einrichtung: Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study & School of Pharmaceutical Science, Hengyang Medical School, Univers…. Hauptthemen laut MEDLINE: Myocardial Infarction, DNA, Mitochondrial, Hydrogels, Myocytes, Cardiac. Die Arbeit wurde bisher 46-mal zitiert (Crossref) und nennt 52 Literaturangaben.
Abstract (Originalsprache)
Myocardial infarction (MI)-induced impaired cardiomyocyte (CM) mitochondrial function and microenvironmental inflammatory cascades severely accelerate the progression of heart failure for compromised myocardial repair. Modulation of the crosstalk between CM mitochondrial DNA (mtDNA) and STING has been recently identified as a robust strategy in enhancing MI treatment, but remains seldom explored. To develop a novel approach that can address persistent myocardial injury using this crosstalk, we report herein construction of a biomimetic hydrogel system, Rb1/PDA-hydrogel comprised of ginsenoside Rb1/polydopamine nanoparticles (Rb1/PDA NPs)-loaded carboxylated chitosan, 4-arm-PEG-phenylboronic acid (4-arm-PEG-PBA), and 4-arm-PEG-dopamine (4-arm-PEG-DA) crosslinked networks. An optimized hydrogel formulation presents not only desired adhesion properties to the surface of the myocardium, but also adaptability for deep myocardial injection, resulting in ROS scavenging, CM mitochondrial function protection, M1 macrophage polarization inhibition through the STING pathway, and angiogenesis promotion via an internal-external spatial combination. The enhanced therapeutic efficiency is supported by the histological analysis of the infarcted area, which shows that the fibrotic area of the MI rats decreases from 58.4% to 5.5%, the thickness of the left ventricular wall increases by 1-fold, and almost complete recovery of cardiac function after 28 days of treatment. Overall, this study reported the first use of a strong adhesive and injectable hydrogel with mtDNA and STING signaling characteristics for enhanced MI treatment via an internal-external spatial combination strategy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study & School of Pharmaceutical Science, Hengyang Medical School, University of South China, 28 W Changsheng Road, Hengyang 421001, Hunan, Chin…
Zitieren
APA
Zheng, Z., Sun, J., Wang, J., He, S., Liu, Z., Xie, J., Yu, C. Y., & Wei, H. (2024). Enhancing myocardial infarction treatment through bionic hydrogel-mediated spatial combination therapy via mtDNA-STING crosstalk modulation. Journal of Controlled Release, 371, 570-587. https://doi.org/10.1016/j.jconrel.2024.06.015
Vancouver
Zheng Z, Sun J, Wang J, He S, Liu Z, Xie J, et al. Enhancing myocardial infarction treatment through bionic hydrogel-mediated spatial combination therapy via mtDNA-STING crosstalk modulation. Journal of Controlled Release. 2024;371:570-587. doi:10.1016/j.jconrel.2024.06.015
BibTeX
@article{Zheng2024,
author = {Zheng, Zhi and Sun, Jian and Wang, Jun and He, Suisui and Liu, Zhenqiu and Xie, Jiahao and Yu, Cui-Yun and Wei, Hua},
title = {Enhancing myocardial infarction treatment through bionic hydrogel-mediated spatial combination therapy via mtDNA-STING crosstalk modulation},
journal = {Journal of Controlled Release},
year = {2024},
volume = {371},
pages = {570--587},
doi = {10.1016/j.jconrel.2024.06.015}
}
EUVIMED